You are here: Industry Insights > RDIF

News List

Dr Reddy’s receives EUA for Sputnik V in India expresspharma
April 14, 2021
Sputnik V uses two different vectors for the two shots in a course of vaccination and its efficacy was determined to be 91.6 per cent as per a published article in the Lancet.
RDIF and Panacea Biotec partner to produce 100 mn doses of Sputnik V vaccine in India annually expresspharma
April 06, 2021
The Russian Direct Investment Fund (RDIF) and Panacea Biotec announce cooperation to produce 100 million doses per year of Sputnik V.
DCGI approval for Sputnik V vaccine expected in next few weeks: Dr Reddy’s official expresspharma
March 30, 2021
Dr Reddy’s Laboratories expects the Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks, a company official has said.
RDIF, Virchow Biotech sign agreement to produce 200 million doses of Sputnik V vaccine expresspharma
March 23, 2021
The technology transfer is expected to be completed in the second quarter of 2021 followed by full-scale commercial production of Sputnik V.
RDIF, Stelis Biopharma join hands for 200 mn doses of Sputnik V vaccine expresspharma
March 22, 2021
The Russian Direct Investment Fund (RDIF), and Stelis Biopharma, the biopharma division of Strides, have partnered to produce, and supply a minimum of 200 million doses of the Russian Sputnik V vaccine against coronavirus sufficient to vaccinate 100 ...
Gland Pharma signs deal with RDIF for 252 million Sputnik V vaccine doses expresspharma
March 17, 2021
Gland Pharma has signed a deal with the Russian Direct Investment Fund (RDIF) to make up to 252 million doses of the Sputnik V COVID-19 vaccine, bringing India’s total production of the shot to at least 352 million.
Egyptian Drug Authority approves Sputnik V vaccine for emergency use pharmaceutical-technology
February 26, 2021
The Egyptian Drug Authority has approved the Russian Direct Investment Fund’s (RDIF) Covid-19 vaccine, Sputnik V, under the emergency use authorisation (EUA) procedure.
Efficacy of Sputnik V against COVID-19 was reported at 91.6% worldpharmanews
February 03, 2021
The Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation and the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announce that The Lancet, one of the world's ...
Algeria registers Russian Sputnik V vaccine against Covid-19 pharmaceutical-technology
January 12, 2021
The Russian Direct Investment Fund (RDIF) has announced the registration of Sputnik V vaccine against Covid-19 by the National Agency of Pharmaceutical Products of People’s Democratic Republic of Algeria.
Argentina registers Russia’s Covid-19 vaccine Sputnik V pharmaceutical-technology
December 25, 2020
The Russian Direct Investment Fund (RDIF) has announced that the National Administration of Drugs, Foods and Medical Devices of Argentina (ANMAT) has registered the Sputnik V vaccine against Covid-19.

Previous page 1 2 3 4 5 Next page